New Presentation definition
Examples of New Presentation in a sentence
GWI may from time to time request Supplier to manufacture Secondary/Steriles Products in package or dosage sizes other than those listed on Schedule 2 ("New Presentation").
If the recalculated Conversion Charge is less than the Conversion Charge calculated prior to the commencement of supply of any such New Presentation, Supplier shall credit to GWI an amount equal to the difference times the number of units of such New Presentation with Delivery Dates in such period on Supplier's next invoices for Products until fully recovered.
If the recalculated Conversion Charge exceeds the Conversion Charge calculated prior to the commencement of supply of any such New Presentation, GWI shall promptly pay to Supplier an amount equal to the excess times the number of units of that New Presentation with Delivery Dates in such period.
Theratechnologies shall have sole control over and decision-making authority with respect to any Development activity within or outside the Territory in connection with the Initial Product, any Additional Product, any Elected Additional Product and any New Presentation.
At any time during the Term, Thera Europe shall have the right to introduce any New Presentation for Commercialization by ▇▇▇▇▇▇.
At any time during the Term, Thera shall disclose any New Presentation to SA.
If the Developing Party, in providing information pertaining to a New Presentation, does or does not characterize the New Presentation as a Combination Product and if the other Party disagrees, such matter (in addition to a determination of [ * ], if applicable) shall be resolved [ * ].
For the avoidance of doubt, the following activities will require the prior written consent of Theratechnologies and, where applicable, Thera Europe prior to be conducted by ▇▇▇▇▇▇: (i) any Clinical Trial for a Product or any New Presentation; (ii) any Phase IV Trial for a Product or any New Presentation; and (iii) any grant for the conduct of a study relating to a Product or any New Presentation.
Pharmion shall not proceed with the development of the Product for an Additional Indication or a New Presentation without first submitting a Development Plan to the Development and Marketing Committee.
Without limitation to the foregoing, the MA Holder shall immediately inform the Non-MA Holder in the event that the MA Holder receives any notice from a Regulatory Authority relating to any finding of deficiency, finding of non-compliance, investigation, penalty for corrective or remedial action or of any other compliance or enforcement action related to a Product or any New Presentation.